Cosentyx Effect on Vaccines
Cosentyx (secukinumab) suppresses IL-17 and weakens immune responses, reducing vaccine effectiveness—especially for live vaccines—and raising infection risk post-vaccination.[1]
Live Vaccines with Cosentyx
Avoid live vaccines (e.g., MMR, varicella, oral polio, yellow fever) during Cosentyx treatment and for 4–6 weeks after stopping. Live vaccines can cause infection in immunocompromised patients.[1][2]
Inactivated and mRNA Vaccines
No required spacing for inactivated vaccines (e.g., flu shot, Tdap, pneumococcal) or mRNA COVID-19 vaccines. Administer them while on Cosentyx, though antibody responses may be lower. Boosters might be needed.[1][3]
Recommended Timing Practices
- Get vaccines before starting Cosentyx if possible.
- Space non-live vaccines around infusions if concerned about local reactions, but guidelines don't mandate it.
- Consult your doctor for personalized advice, as individual immune status varies.[1][2]
Patient Reports and Real-World Data
Some patients report mild injection-site reactions when vaccinating on the same day as Cosentyx, but no widespread issues. Studies show COVID-19 vaccines remain safe and somewhat effective on biologics like Cosentyx.[3]
[1]: Cosentyx Prescribing Information (Novartis)
[2]: CDC Guidelines on Immunosuppressants and Vaccines
[3]: Study on Secukinumab and Vaccine Response (PubMed)